Archive for June 2011

Microsoft and Qualcomm’s Collaboration equals Mobile Computing Opp

Microsoft and Qualcomm’s Collaboration equals Mobile Computing Opp

Microsoft Corporation’s (NASDAQ: MSFT) has previewed a new version of its operating system, Windows 8, that could run on both personal computers (PC) and mobile devises like tablet computers and smartphones. As a result, Microsoft is one-step closer to tap into the tablet opportunity; however, the company still needs a tablet device to run the Windows 8, as the operating - Continue Reading »

Stock Alert for Orexigen Therapeutics Inc. (OREX)

Orexigen Therapeutics Inc. (OREX) is a biopharmaceutical company focused on the treatment of obesity. The Company’s lead product, Contrave, has completed phase III clinical trials and has received a Complete Response Letter from the FDA for its New Drug Application.  The Company is in the process of determining the next steps for Contrave.  Its second product, Empatic, has completed phase - Continue Reading »

Stock Alert for The Brainy Brands Company (TBBC)

The Brainy Brands Company Inc. (TBBC) engages in the development and marketing of an extensive library of early childhood learning products, including a full range of puzzles, books, games, toys and audio-visual materials for the U.S. market and international marketplace. The Company’s strategy is to support its existing line of high quality educational toys, media, and activities and develop new - Continue Reading »

The Name of the Game; Shanda inches up on Q1 Results

Shanda Games Limited’s (NASDAQ: GAME) shares increased 2.2% this morning, moving on the company’s first-quarter results, which topped analyst estimates. The stock has gained 11% this year, driven by the rebounding growth in the second half of 2010 and the surge in China’s online activity, both in Internet gaming and social networking. - Continue Reading »

Stock Alert for MultiCell Technologies Inc. (MCET)

MultiCell Technologies Inc. (MCET) is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. The Company’s therapeutic development platform relies on several patented technologies used to: isolate, characterize and differentiate stem cells from human liver, or control the immune response at transcriptional and translational - Continue Reading »